These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38927624)

  • 1. Gene Abnormalities and Modulated Gene Expression Associated with Radionuclide Treatment: Towards Predictive Biomarkers of Response.
    Smith TAD
    Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy.
    O'Neill E; Cornelissen B
    Nucl Med Biol; 2022; 108-109():44-53. PubMed ID: 35276447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy.
    Forker LJ; Choudhury A; Kiltie AE
    Clin Oncol (R Coll Radiol); 2015 Oct; 27(10):561-9. PubMed ID: 26119726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNAs and radiotherapy response in prostate cancer.
    Konoshenko MY; Bryzgunova OE; Laktionov PP
    Andrology; 2021 Mar; 9(2):529-545. PubMed ID: 33053272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy of prostate cancer.
    Smith-Jones PM
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):297-304. PubMed ID: 15640793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts.
    Lucas S; Feron O; Gallez B; Masereel B; Michiels C; Vander Borght T
    Comput Math Methods Med; 2015; 2015():284360. PubMed ID: 26136812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging and therapy of tumors induced to express somatostatin receptor by gene transfer using radiolabeled peptides and single chain antibody constructs.
    Buchsbaum DJ
    Semin Nucl Med; 2004 Jan; 34(1):32-46. PubMed ID: 14735457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tomoregulin for radioimmunotherapy of prostate cancer.
    Zhao XY; Schneider D; Biroc SL; Parry R; Alicke B; Toy P; Xuan JA; Sakamoto C; Wada K; Schulze M; Müller-Tiemann B; Parry G; Dinter H
    Cancer Res; 2005 Apr; 65(7):2846-53. PubMed ID: 15805286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review.
    Kachroo N; Gnanapragasam VJ
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):1-24. PubMed ID: 23187933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.
    Boufaied N; Takhar M; Nash C; Erho N; Bismar TA; Davicioni E; Thomson AA
    J Pathol; 2019 Dec; 249(4):411-424. PubMed ID: 31206668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistributions of 177Lu- and 111In-labeled 7E11 antibodies to prostate-specific membrane antigen in xenograft model of prostate cancer and potential use of 111In-7E11 as a pre-therapeutic agent for 177Lu-7E11 radioimmunotherapy.
    Pan MH; Gao DW; Feng J; He J; Seo Y; Tedesco J; Wolodzko JG; Hasegawa BH; Franc BL
    Mol Imaging Biol; 2009; 11(3):159-66. PubMed ID: 19034582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technological advances in radioimmunotherapy.
    Dearling JL; Pedley RB
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):457-69. PubMed ID: 17537620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancer.
    Altintas DM; Allioli N; Decaussin M; de Bernard S; Ruffion A; Samarut J; Vlaeminck-Guillem V
    PLoS One; 2013; 8(6):e66278. PubMed ID: 23840433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic advances of nuclear medicine in oncology].
    Valdés Olmos RA; Hoefnagel CA; Bais E; Boot H; Taal B; de Kraker J; Vote PA
    Rev Esp Med Nucl; 2001 Dec; 20(7):547-57. PubMed ID: 11709141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
    Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
    BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.
    Alinezhad S; Väänänen RM; Mattsson J; Li Y; Tallgrén T; Tong Ochoa N; Bjartell A; Åkerfelt M; Taimen P; Boström PJ; Pettersson K; Nees M
    PLoS One; 2016; 11(5):e0155901. PubMed ID: 27196083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The radiobiology of targeted radiotherapy.
    Wheldon TE; O'Donoghue JA
    Int J Radiat Biol; 1990 Jul; 58(1):1-21. PubMed ID: 1973428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer.
    Tanić M; Krivokuća A; Čavić M; Mladenović J; Plesinac Karapandžić V; Beck S; Radulović S; Susnjar S; Janković R
    Radiat Oncol; 2018 Oct; 13(1):193. PubMed ID: 30285791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The direct route may not be the best way to home.
    Sharkey RM
    J Nucl Med; 2005 Mar; 46(3):391-4. PubMed ID: 15750148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.